Arcus Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-256.0M | $-282.0M | $26.0M | $55.0M |
| FY2022 | $438.0M | $432.0M | $6.0M | $65.0M |
| FY2023 | $-306.0M | $-330.0M | $24.0M | $73.0M |
| FY2024 | $-170.0M | $-176.0M | $6.0M | $76.0M |
| FY2025 | $-482.0M | $-484.0M | $2.0M | $60.0M |